FINHUB Insights

Language: EN
Sign in Sign up

Cencora Q3 FY24: where the revenue came from and where it went

The whole income statement of Cencora for this quarter, as one diagram: what earned the revenue, and what it went on.

Period
Apr 1 – Jun 30, 2024
Reported
Jul 31, 2024 10-Q accession 0001140859-24-000119

Revenue$74.24B +11% year over year
Gross profit$2.41B 3% margin
Operating profit$0.67B 1% margin
Net profit$0.48B 1% margin
100% free

It's free. All of it.

A free account opens every diagram. We send one link to confirm your address, and that is the whole of it.

Continue with Google Create a free account

Already have an account? Sign in

The numbers

All figures in billions of U.S. dollars, for Q3 FY24 (period ends Jun 30, 2024).
ItemValueShare of revenueYear over year
Revenue 74.24 100% +11%
US healthcare solutions 67.19 91% +12%
International healthcare 7.05 9% +0%
Cost of revenue−71.8397%
Gross profit2.413% margin+0pp
SG&A−1.382%+0pp
Other−0.360%+0pp
Operating profit0.671% margin+0pp
Tax−0.19
Net profit0.48 1% margin+0pp

Source of the numbers: structured XBRL data from the filing (10-Q). The diagram is generated automatically and checked against EDGAR before release. How we calculate it → About and methodology.

Filing on EDGAR More quarters of COR

112 of 418 companies, most recently reported first